Biologics Market, By Product, By Application, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023

Description

Biologics is a product that is produced from living organisms or contain components of living organisms. Biologics are medicines that are developed from blood, proteins, viruses, or living organisms, and are used to prevent, treat, and cure many health conditions. Biologicals are a diverse group of medicines which includes vaccines, growth factors, immune modulators, monoclonal antibodies, as well as products derived from human blood and plasma. The main types of biologics are monoclonal antibodies (MAbs), therapeutic proteins, and vaccines. Monoclonal antibodies, or mAbs, are created in a laboratory to combat a specific infection. Biologic drugs are the most advanced therapies available for the treatment of a wide range of diseases and conditions. Certain biologic medications are used to treat Crohn's disease, ulcerative colitis, rheumatoid arthritis, and other autoimmune diseases. Biologics have transformed cancer treatment, delayed or reversed the progression of immune-related conditions, transformed the lives of people with rare diseases, and given hope to many patients who previously had no effective treatment options for their condition.

Market Dynamics

Increasing burden of infectious, autoimmune, and chronic diseases, and rising demand for biologics, higher acceptability for innovative therapies, increasing number of clinical trials and research and development activities are the major factors that are expected to drive growth of the global biologics market during the forecast period. Moreover, in March 2022, TG Therapeutics Inc., Biopharmaceutical Company hasannounced that U.S. FDA extended the prescription drug user fee act (PDUFA) for Instance June 25, 2022, for the Biologics License Application for ublituximab for treatment of patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.

Key features of the study:

This report provides in-depth analysis of the global biologics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global biologics market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis AG, AstraZeneca PLC, Bayer AG., Sanofi SA, Pfizer Inc, Merck & Co., Johnson and Johnson, GlaxoSmithKline PLC, Amgen Inc AbbVie Inc, F. Hoffmann-La Roche AG, Eli Lilly and Company, and AGC Biologics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global Biologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biologics market

Detailed Segmentation:

Global Biologics market, By Product:
- Monoclonal Antibodies
- Vaccines
- Recombinant Hormones/Proteins
- Cellular-based Biologics
- Gene-based Biologics
- Others
Global Biologics market, By Application:
- Cancer
- Infectious Diseases
- Autoimmune Diseases
- Others
Global Biologics Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC Countries
- Israel
- Rest of Middle East
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Novartis AG
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AstraZeneca PLC
- Bayer AG
- Sanofi SA
- Pfizer Inc
- Merck & Co
- Johnson and Johnson
- GlaxoSmithKline PLC
- Amgen Inc
- AbbVie Inc
- F. Hoffmann-La Roche AG
- Eli Lilly and Company
- AGC Biologics

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI2663

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Merger, Acquisition, and Collaborations
Product Launch
Regulatory Scenario
PEST Analysis

4. Global Biologics Market- Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Biologics Market, By Product, 2017-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Recombinant Hormones/Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Cellular-based Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Gene-based Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

6. Global Biologics Market, By Application, 2017 - 2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

7. Global Biologics Market, By Region, 2017 - 2030, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
China
Japan
India
Australia
ASEAN
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Billion)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck & Co
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GlaxoSmithKline PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amgen Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AbbVie Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
F. Hoffmann-La Roche AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AGC Biologics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

9. Section

Research Methodology
About Us

Biologics Market, By Product, By Application, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030